The Krönke Lab focusses on Hematologic Malignancies at the Department of Hematology and Oncology, Charité – Universitätsmedizin Berlin
Berlin, Germany
Joined October 2020
- Tweets19
- Following145
- Followers192
- Likes19
Krönke Lab retweeted
Anti-BCMA TCE in newly diagnosed myeloma. New era is here, end of HCT? congrats @RaabMarc @RascheLeo nature.com/articles/s41591-0…
Krönke Lab retweeted
Protein-Genomics Myeloma Session #ASH24 chaired by Dr Paola Neri @FrancescoMaura4 @kronkelab @fabianaperna
Krönke Lab retweeted
Early View | Haematologica haematologica.org/article/vi…
Finally first results from our Phase 1 TCR study targeting MAGE-A1 in myeloma!
Hopefully more to come in advanced solid tumors where need for innovative (cellular) therapies is still HUGE.
Krönke Lab retweeted
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Happy to share that our #proteogenomic study of multiple myeloma led by Evelyn Ramberger is out now @NatureCancer rdcu.be/dL9wZ
@MDC_Berlin @ChariteBerlin @berlinnovation
Our multiomics analysis including deep TMT-based (phospho)proteomics, RNA sequencing, and nanopore DNA sequencing of 138 primary multiple myeloma samples reveals new insights into disease biology and treatment opportunities
Krönke Lab retweeted
We had a record number of (high quality) abstracts for this year’s Mol Hem workshop @EHA_Hematology annual meeting. Check out the 12 selected talks ehaweb.org/congress/eha2024-…
Krönke Lab retweeted
Our paper on using heteroPROTACs to induce potent pan-IAP degradation is finally out! Check out our results from the IAP vs VHL&CRBN battle 🥊—> bit.ly/3K0aMCp
Very happy about this great collaboration with our established team 😁@IzidorSosic @c_steinebach, @KroenkeLab
Krönke Lab retweeted
Excited to announce that our lab has been awarded an #ERC_StG grant to study immunological interactions in leukemias. Thanks to our team members, collaborators, friends and family for the constant support!
@berlinnovation @MDC_Berlin @ChariteBerlin @ERC_Research
📢 The ERC's 2022 Starting Grant competition results are now revealed. Over €636 million to fund the best ideas of younger scientists.
Find out who, where and why 👉 bit.ly/3JRyDDg
🇪🇺#EUfunded @HorizonEU #FrontierResearch #ERCStG
Krönke Lab retweeted
It's the E3 ligase Smac-down!🥊VHL and CRBN face IAPs head to head.🥊Who shall prevail? Welp, our preprint title gives it out, IAPs get totally K.O.'d. bit.ly/3QHGGEV. A great collaboration from @c_steinebach, @KroenkeLab, @AlesaBricelj and @IzidorSosic #TPD #PROTACs
Krönke Lab retweeted
Very excited to share our latest work, now published online first in @CD_AACR!
Unleashing cell-intrinsic inflammation as a strategy to kill AML blasts aacrjournals.org/cancerdisco…
Krönke Lab retweeted
We employed the BTB domain of transcription factor BCL6 as small-molecule-controlled reversible oligomerization switch. Led by @lena_nitsch and my first corresponding author manuscript @CellRepMethods 1/16 cell.com/cell-reports-method…
Happy to announce our new work identifying cdk6 in lenalidomide resistant multiple myeloma published in @NatureComms rdcu.be/cHA4R great collaboration @ChariteBerlin @MDC_Berlin
Check our new paper Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma | Blood Advances | American Society of Hematology ashpublications.org/bloodadv…